Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2020 1
2021 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).
Nguyen-Khac F, Baron M, Guièze R, Feugier P, Fayault A, Raynaud S, Troussard X, Droin N, Damm F, Smagghe L, Susin S, Leblond V, Dartigeas C, Van den Neste E, Leprêtre S, Bernard OA, Roos-Weil D; on behalf the FILO (French Innovative Leukaemia Organization) Group. Nguyen-Khac F, et al. Among authors: fayault a. Br J Haematol. 2024 Aug;205(2):495-502. doi: 10.1111/bjh.19459. Epub 2024 Apr 23. Br J Haematol. 2024. PMID: 38654616
[Legal aspects of consent in children (Part 1)].
Nacka F, Benadjaoud L, Fayon M, Jacqz-Aigrain E; Membres du Réseau Pédiatrique Inserm des Centres d'investigations cliniques (CIC); Demarez JP. Nacka F, et al. Arch Pediatr. 2015 Sep;22(9):983-8. doi: 10.1016/j.arcped.2015.06.013. Epub 2015 Jul 27. Arch Pediatr. 2015. PMID: 26228811 Review. French.
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.
Largeaud L, Cornillet-Lefebvre P, Hamel JF, Dumas PY, Prade N, Dufrechou S, Plenecassagnes J, Luquet I, Blanchet O, Banos A, Béné MC, Bernard M, Bertoli S, Bonmati C, Fornecker LM, Guièze R, Haddaoui L, Hunault M, Ianotto JC, Jourdan E, Ojeda M, Peterlin P, Vey N, Zerazhi H, Yosr H, Mineur A, Cahn JY, Ifrah N, Récher C, Pigneux A, Delabesse E; French Innovative Leukemia Organization (FILO). Largeaud L, et al. Leukemia. 2021 May;35(5):1291-1300. doi: 10.1038/s41375-020-01031-1. Epub 2020 Sep 18. Leukemia. 2021. PMID: 32943750 Clinical Trial.
[Consent in children: Practical situations (part 2)].
Nacka F, Benadjaoud L, Fayon M, Jacqz-Aigrain E; \membres du réseau pédiatrique Inserm des centres d'investigations cliniques (CIC); Demarez JP. Nacka F, et al. Arch Pediatr. 2015 Sep;22(9):989-95. doi: 10.1016/j.arcped.2015.06.010. Epub 2015 Jul 27. Arch Pediatr. 2015. PMID: 26228807 French.